Certified by Founder Lodge
DalCor Pharmaceuticals
Canada - Montreal, Québec
START UP
1 Disclosed Funding Rounds $80,000,000
0 Participating Investments
-
Founded date
2015
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
DalCor Pharmaceuticals: DalCor Pharmaceuticals is pioneering precision medicine for patients with cardiovascular disease. By combining genetic and clinical insights, the company’s development
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 22 ,2023 | Series D | $80,000,000 |
Investissement Québec
Fonds de solidarité FTQ
CTI Life Sciences Fund
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Distribusion Technologies | $80,000,000 | (Sep 27, 2024)
Quorum | Undisclosed Amount | (Sep 27, 2024)
Convergence | $12,000,000 | (Sep 27, 2024)
Tetrix | $5,000,000 | (Sep 27, 2024)
AmpUp | $15,000,000 | (Sep 27, 2024)
